Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Supplemented Analgesia on Long-term Survival in Elderly Patients After Cancer Surgery
NCT03012971Active, not recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in cancer (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Overall Survival at 9 years. Started Jan 2017; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cancer
Beyond the preview
Go deeper on NCT03012971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03012971.